Summary by Futu AI
On June 11, 2024, Aitigong Maternal and Infant Health Co., Ltd. ('Aitigong') issued a voluntary announcement announcing its plans to merge its shares. This is based on the fact that the company's share trading price has been consistently below HKD 0.10 in the past four months. According to Rule 13.64 of the Listing Rules of the Stock Exchange and the Trading Arrangements Guide, the company may need to adjust its trading methods to comply with the regulations. Aitigong stated that the specific details, expected timeline, and related terms of the share merger will be announced at the appropriate time. Shareholders and potential investors of the company should exercise caution in trading and seek professional advice when necessary. Members of the board of directors include executive directors Ms. Wang Aier, Mr. Lin Jiang, Mr. Li Runping, and Ms. Meng Lijia; non-executive director Mr. Li Jialong; and independent non-executive directors Mr. Huang Yaojie and Mr. Lin Zhiying.